Skip to main content

and
  1. Article

    Open Access

    Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis

    BRCA1 interacting helicase 1 (BRIP1) alteration was crucial in tumors and it was a potential therapeutic target in ovarian serous cystadenocarcinoma (OV). Although a small number of studies had focused on BRIP...

    Guo Long, Kuan Hu, **aofang Zhang, Ledu Zhou, Juanni Li in Scientific Reports (2023)

  2. Article

    Open Access

    An integrative pan cancer analysis of RET aberrations and their potential clinical implications

    RET (rearranged during transfection), encoding a tyrosine kinase receptor, is a novel therapeutic target for cancers. The aberrations of RET are commonly found in cancers. Here, we profiled a comprehensive gen...

    Lei Zhou, Juanni Li, **aofang Zhang, Zhijie Xu, Yuanliang Yan in Scientific Reports (2022)

  3. Article

    Open Access

    Hotair promotes the migration and proliferation in ovarian cancer by miR-222-3p/CDK19 axis

    Previous studies in our laboratory have reported that miR-222-3p was a tumor-suppressive miRNA in OC. This study aims to further understand the regulatory role of miR-222-3p in OC and provide a new mechanism f...

    Lili Fan, Han Lei, Ying Lin, Zhengwei Zhou in Cellular and Molecular Life Sciences (2022)

  4. Article

    Open Access

    Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer

    Oxaliplatin is widely used in the frontline treatment of colorectal cancer (CRC), but an estimated 50% of patients will eventually stop responding to treatment due to acquired resistance. This study revealed t...

    Yimin Li, Yaqi Gan, Jiaxin Liu, Juanni Li in Signal Transduction and Targeted Therapy (2022)

  5. Article

    Open Access

    Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis

    Accumulating evidence has revealed the role of microRNAs (miRs) in hepatocellular carcinoma (HCC). Dexmedetomidine, a highly selective α2-adrenergic agonist, is widely used in perioperative settings for analgesia...

    Lei Zhou, Juanni Li, **ng Liu, Yongzhong Tang, Tunliang Li in Cell Death Discovery (2022)

  6. Article

    Open Access

    Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications

    Alterations of mitogen-activated protein kinase kinase 1 (MEK1) are commonly associated with tumorigenesis, and MEK1 is thought to be a suitable targeted therapy for various cancers. However, abnormal MEK1 alt...

    Zhiyang Zhou, Bi Peng, Juanni Li, Kewa Gao, Yuan Cai, Zhijie Xu in Scientific Reports (2021)

  7. No Access

    Article

    CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential

    Deaths from ovarian cancer usually occur when patients succumb to overwhelmingly numerous and widespread micrometastasis. Whereas epithelial–mesenchymal transition is required for epithelial ovarian cancer cel...

    Juanni Li, Ayesha B. Alvero, Sudhakar Nuti, Roslyn Tedja, Cai M. Roberts in Oncogene (2020)

  8. Article

    Open Access

    Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression

    MicroRNAs (miRNAs) function as critical regulators of gene expression and their deregulation is associated with the development and progression of various cancers. This study aimed to investigate the biologica...

    Juanni Li, Kuan Hu, Guanghui Gong, Ding Zhu, Yixuan Wang, Hailing Liu in Scientific Reports (2017)